Gandeeva Therapeutics
the SPOTLIGHT platform integrating cryo-EM with machine-learning binding prediction; in June 2026 it partnered with Zymeworks to accelerate antibody drug discovery.
- Country
- Canada
Coverage
| CN | EU | US | |
|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Structural biology (cryo-EM CRO) | bioinformatics-omics | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.